YTD Return: +61%
Investor: Rick Pendergraft
Little did he know that the S&P 500 itself would gain almost 30% in the first 11 months … or that MYL would more than double that.
Yes, Pendergraft’s pick is blowing away most of the other wannabe best stocks of 2013 heading into the homestretch, and has nosed ahead of its main competitor.
What does our leader in the Best Stocks for 2013 contest do? Well, Mylan makes generic and branded generic drugs, boasting more than 1,000 generic products sold in over 150 countries. Can that business send Mylan stock even higher — or at least help it hold onto its lead for one more month?
Stay tuned to find out how the Best Stocks of 2013 showdown shakes out.
As of this writing, Alyssa Oursler did not hold a position in any of the aforementioned securities.